Summary
The formation ofp-hydroxytranylcypromine from intraperitoneally injected tranylcypromine was confirmed using two types of experiments. In the first, tranylcypromine levels were shown to be increased in brains of rats pretreated with agents known to be inhibitors of ring hydroxylation compared to rats pretreated with physiological saline. For the second set of experiments,p-nydroxytranylcypromine was identified in brain and urine (following intraperitoneal injection) by derivatizing with perfluoroacylating reagents and analyzing by electron-capture gas chromatography and by combined gas chromatography-mass spectrometry. In experimentsin vitro, p-hydroxytranylcypromine was demonstrated to inhibit monoamine oxidase, although it was weaker than TCP in this regard and was a much stronger inhibitor of MAO-A than of MAO-B.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alleva, J. J.: Metabolism of tranylcypromine-C14 in the rat. J. Med. Chem.6, 621–624 (1965).
Axelrod, J.: Studies on the sympathomimetic amines II. The biotransformation and physiological disposition of D-amphetamine and D-p-hydroxyamphetamine. J. Pharmacol. Exp. Ther.110, 315–326 (1954).
Baker, G. B., Hiob, L. E., Dewhurst, W. G.: Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytryptamine from rat striatumin vitro. Cell Mol. Biol.26, 182–186 (1980).
Baker, G. B., LeGatt, D. F., Coutts, R. T.: A gas chromatographic procedure for quantifacation of para-tyramine in rat brain. J. Neurosci. Methods5, 181–188 (1982).
Billings, R. E., Murphy, P. J., McMahon, R. E., Ashmore, J.: Aromatic hydroxylation of amphetamine with rat liver microsomes, perfused liver, and isolated hepatocytes. Biochem. Pharmacol.27, 2525–2529 (1978).
Cho, A. K., Fischer, J. F., Schaeffer, J. C.: The accumulation ofp-hydroxyamphetamine by brain homogenates and its role in release of catecholamine. Biochem. Pharmacol.26, 1367–1372 (1977).
Coutts, R. T., Prelusky, D. B., Baker, G. B.: Determination of amphetamine, norephedrine and their phenolic metabolite in rat brain by gas-liquid chromatography. J. Pharm. Sci.73, 808–812 (1984).
Freeman, J. J., Sulser, F.: Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action. J. Pharmacol. Exp. Ther.183, 307–315 (1972).
Fuller, R. W., Hemrick-Leucke, S.: Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science209, 305–307 (1980).
Hampson, D. R., Baker, G. B., Nazarali, A. J., Coutts, R. T.: A rapid and sensitive electron-capture gas chromatographic method for the analysis of tranylcypromine in brain tissue. J. Biochem. Biophys. Methods9, 85–87 (1984).
Hendley, E. D., Snyder, S. H.: Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy. Nature (Lond.)220, 1330–1331 (1968).
Lyons, H.A., Degerli, M.: Indications for the use of tranylcypromine and trifluperazine (Parstelin). Scott Med. J.23, 307–309 (1978).
Reynolds, G. P., Garrett, N. J.: The effects of some monoamine oxidase inhibitors and related compounds on [3H]-5-hydroxytryptamine binding to human cortex. J. Pharm. Pharmacol.36 (Suppl.), 45W (1984).
Riederer, P., Reynolds, G. P., Youdim, M. B. H.: Selectivity of MAO inhibitors in the human brain and their clinical consequences. In: Monoamine Oxidase Inhibitors: The State of the Art, (Youdim, M. B. H., Paykel, E. S., eds.), pp. 63–76. Chichester: Wiley. 1981.
Schildkraut, J. J.: Tranylcypromine: effects on norepinephrine metabolism in rat brain. Am. J. Psychiat.126, 925–931 (1970).
Siris, S. G., Cooper, T. B., Rifktin, A. E., Brenner, R., Lieberman, J. A.: Plasma imipramine concentrations in patients receiving concomitant fluphenazine. Am. J. Psychiat.139, 104–106 (1982).
Wurtman, R. J., Axelrod, J.: A sensitive and specific assay for the estimation of monoamine oxidase. Biochem. Pharmacol.12, 1439–1440 (1963).
Youdim, M. B., Aroson, J. K., Blau, K., Green, A. R., Grabame-Smith, D. G.: Tranylcypromine overdose: measurement of tranylcypromine concentration and MAO inhibitory activity and identification of amphetamines in plasma. Psychol. Med.9, 377–382 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baker, G.B., Hampson, D.R., Courts, R.T. et al. Detection and quantitation of a ring-hydroxylated metabolite of the antidepressant drug tranylcypromine. J. Neural Transmission 65, 233–243 (1986). https://doi.org/10.1007/BF01249085
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01249085